News

March 6, 2012 — Medtronic Inc. announced the launch of the CapSure Sense MRI SureScan pacing leads, which are approved for use during magnetic resonance imaging (MRI), and the receipt of the CE mark.

Home March 06, 2012
Home
Technology

March 6, 2012 — TeraRecon announced the release of version 4.4.7 of its iNtuition enterprise advanced visualization image management solution, with enhanced support for interoperability and Quantitative Imaging, at the 23rd European Congress of Radiology (ECR) meeting in Vienna, Austria, in March 2012.

Home March 06, 2012
Home
News

March 5, 2012 — SynCardia Systems Inc., manufacturer of the world’s first and only U.S. Food and Drug Administration (FDA), Health Canada and Conformité Européenne (CE) approved Total Artificial Heart, announced that 18-year-old Jordan Merecka was successfully bridged to a heart transplant at Texas Children’s Hospital in Houston, Texas, after 160 days of support with the SynCardia temporary Total Artificial Heart.

Home March 05, 2012
Home
Technology

March 5, 2012 — Emerge Clinical Solutions announced its strategic relationship with MedAxiom, a comprehensive subscription-based service provider and information resource exclusively for cardiology practices.

Home March 05, 2012
Home
News

March 5, 2012 — Baxter International Inc. announced that it initiated a phase III pivotal clinical trial to evaluate the efficacy and safety of adult autologous (individual’s own) CD34+ stem cells to increase exercise capacity in patients with chronic myocardial ischemia (CMI).

Home March 05, 2012
Home
News

March 1, 2012 — Cell>Point announced it entered into a licensing agreement for South Korea, Taiwan, Malaysia, Vietnam and the Philippines with Hyun Imc Co. Ltd., headquartered in Seoul, South Korea, for the kit manufacture, marketing and distribution of Cell>Point’s cancer and cardiology nuclear imaging product.

Home March 01, 2012
Home
Technology

March 1, 2012 — Philips announced the launch of HeartStart XL+, a crash cart defibrillator/monitor for use in hospitals and other health care facilities that, in AED mode, can defibrillate any patient with no special pads required, which can save valuable time when responding to a cardiac emergency.

Home March 01, 2012
Home
Technology

March 1, 2012 – Steris Corp. announced they will collaborate with device manufacturer St. Jude Medical Inc. on the planning and implementation of advanced cardiac laboratories for healthcare providers in the United States. The labs feature technologies across the cardiovascular service line for hospitals and clinics interested in developing laboratories that meet their changing clinical needs.

Home March 01, 2012
Home
News

February 29, 2012 — Vessix Vascular Inc. announced initial patient treatments in the international multi-center Reduce-HTN renal denervation clinical study for uncontrolled hypertension.

Home February 29, 2012
Home
News

February 29, 2012 — Lantheus Medical Imaging Inc. announced a strategic distribution arrangement for its Definity cardiac ultrasound contrast agent in the People’s Republic of China, including Hong Kong S.A.R. and Macau S.A.R.

Home February 29, 2012
Home
News

February 28, 2012 — Janssen Research and Development LLC announced that the U.S. Food and Drug Administration (FDA) has assigned a priority review designation to the supplemental new drug application (sNDA) filed Dec. 29, 2011 for Xarelto (rivaroxaban).

Home February 28, 2012
Home
Feature

Based on what readers clicked on throughout 2011 on DIcardiology.com, following is a list of the top 25 most popular stories.

Home February 28, 2012
Home
Technology

February 28, 2012 — AccessClosure Inc. announced the U.S. Food and Drug Administration (FDA) approval and U.S. launch of the MynxGrip Vascular Closure Device (VCD). Built on the Mynx platform, the MynxGrip VCD offers an active, extravascular and patient-friendly vascular closure solution.

Home February 28, 2012
Home
News

February 28, 2012 — nContact Inc. announced a new preclinical study examining a unique minimally invasive percutaneous approach to accessing the heart that may enable electrophysiologists (EPs) to perform epicardial ablation for ventricular tachycardia (VT). The study was published in the February 2012 issue of The Journal of Innovations in Cardiac Rhythm Management.

Home February 28, 2012
Home
News

University Hospitals Case Medical Center and Case Western Reserve University School of Medicine (CWRU) researchers have uncovered a genetic factor that controls arrhythmias, the primary cause of sudden cardiac death (SCD) in the United States. The study will be published in the upcoming March edition of Nature entitled, “Circadian rhythms govern cardiac repolarization and arrhythmogenesis.”

Home February 28, 2012
Home
Subscribe Now